These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 20008886

  • 1. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT).
    Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Alexopoulou E, Kolibianakis EM.
    Hum Reprod; 2010 Mar; 25(3):683-9. PubMed ID: 20008886
    [Abstract] [Full Text] [Related]

  • 2. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 3. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.
    Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, van der Veen F, van Wely M.
    Hum Reprod Update; 2017 Sep 01; 23(5):560-579. PubMed ID: 28903472
    [Abstract] [Full Text] [Related]

  • 4. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S, Alhalabi M, Nattouf AH.
    Sci Rep; 2022 Mar 15; 12(1):4456. PubMed ID: 35292717
    [Abstract] [Full Text] [Related]

  • 5. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M, Chaker A, Bouyahia M, Zhioua F, Zhioua A.
    Tunis Med; 2009 Dec 15; 87(12):834-42. PubMed ID: 20209851
    [Abstract] [Full Text] [Related]

  • 6. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C.
    Fertil Steril; 2008 Jan 15; 89(1):84-91. PubMed ID: 17462639
    [Abstract] [Full Text] [Related]

  • 7. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M, Son WY, Buckett W, Tulandi T, Holzer H.
    Reprod Biomed Online; 2014 Nov 15; 29(5):545-51. PubMed ID: 25262236
    [Abstract] [Full Text] [Related]

  • 8. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN, Peng JL, Yang J, Xu WM.
    Curr Med Sci; 2019 Jun 15; 39(3):431-436. PubMed ID: 31209815
    [Abstract] [Full Text] [Related]

  • 9. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
    Zheng X, Guo W, Zeng L, Zheng D, Yang S, Xu Y, Wang L, Wang R, Mol BW, Li R, Qiao J.
    Hum Reprod; 2022 Jan 28; 37(2):242-253. PubMed ID: 34849920
    [Abstract] [Full Text] [Related]

  • 10. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.
    Prapas Y, Petousis S, Dagklis T, Panagiotidis Y, Papatheodorou A, Assunta I, Prapas N.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jan 28; 166(1):43-6. PubMed ID: 23020996
    [Abstract] [Full Text] [Related]

  • 11. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.
    Jacob SL, Brewer C, Tang T, Picton HM, Barth JH, Balen AH.
    Hum Reprod; 2016 Dec 28; 31(12):2756-2764. PubMed ID: 27816925
    [Abstract] [Full Text] [Related]

  • 12. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles.
    Kim YJ, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM, Kim JG, Moon SY.
    Arch Gynecol Obstet; 2010 Aug 28; 282(2):199-205. PubMed ID: 20182736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 28; 179():46-50. PubMed ID: 24965979
    [Abstract] [Full Text] [Related]

  • 15. Flexible GnRH antagonist protocol vs. long GnRH agonist protocol in patients with polycystic ovary syndrome treated for IVF: comparison of clinical outcome and embryo quality.
    Trenkić M, Popović J, Kopitović V, Bjelica A, Živadinović R, Pop-Trajković S.
    Ginekol Pol; 2016 Aug 28; 87(4):265-70. PubMed ID: 27321097
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR, Xiao SQ, Zhao JZ, Lin J, Wang PY, Jin CC, Jin WM.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 28; 48(11):833-7. PubMed ID: 24444560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.
    Lin H, Li Y, Li L, Wang W, Yang D, Zhang Q.
    PLoS One; 2014 Nov 28; 9(3):e91796. PubMed ID: 24642641
    [Abstract] [Full Text] [Related]

  • 20. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
    Tehraninejad ES, Nasiri R, Rashidi B, Haghollahi F, Ataie M.
    Arch Gynecol Obstet; 2010 Sep 28; 282(3):319-25. PubMed ID: 20379731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.